Clinical Trial Update: Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial of palifermin in patients with locally advanced head and neck cancer undergoing radiation and chemotherapy; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Palifermin (palifermin)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Head and Neck Cancer, Mucositis | Phase 3 | Status: TERMINATED | Results posted: 2014-05-15